The FDA is Reversing Course on Unapproved Products Sold by Stem Cell Manufacturers
The FDA’s “untitled letter” to R3 Stem Cell (R3), based in Scottsdale Arizona, cautioned R3 that the product they are marketing is considered a drug. It must, therefore, be…